N-[5-(1,2,4-triazole-1-yl)thiazole-2-yl]aromatic amide, and pharmaceutical applications thereof
A technology of thiazole and benzamide, applied in the field of application of N-[5-(1, preparation of influenza virus neuraminidase inhibitors
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0016] Preparation of N-[4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-yl]benzamide
[0017] 2mmol of 4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-amine was dissolved in 20.0mL of tetrahydrofuran, 8mmol of anhydrous potassium carbonate was added, and 3mmol of benzyl was added dropwise under stirring in an ice bath Acyl chloride, stirred at room temperature, reacted for 2.0h, filtered, the filtrate was rotary evaporated, and column chromatography gave N-[4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-yl] Benzamide, yield 70.2%, m.p.257~260℃. 1 H NMR (400MHz, CDCl 3 ) δ: 1.17 (s, 9H, 3×CH 3 ), 7.55 (t, J=7.6Hz, 2H, C 6 h 5 3,5-H), 7.65(t, J=7.6Hz, 1H, C 6 h 5 4-H), 7.97(d, J=7.6Hz, 2H, C 6 h 5 2,6-H), 8.13 (s, 1H, C 2 N 3 h 2 3-H), 8.28 (s, 1H, C 2 N 3 h 2 5-H), 9.51 (s, 1H, NH).
Embodiment 2
[0019] Preparation of N-[4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-yl]-2-methoxybenzamide
[0020] 2mmol of 4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-amine was dissolved in 20.0mL of dichloromethane, 2.2mmol of 2-methoxybenzoic acid was added, 0.03g of 4-di Dimethylaminopyridine (DMAP), after 0.5h, add 2.2mmol N,N'-dicyclohexylcarbodiimide (DCC), stir at room temperature, react for 8.0h, the reaction solution is neutralized with aqueous sodium bicarbonate solution, stand still, and separate layer, the organic layer was dried over anhydrous sodium sulfate, filtered, rotary evaporated, and column chromatography gave N-[4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-yl ]-2-methoxybenzamide, yield 46.7%, m.p.178~180℃. 1 H NMR (400MHz, CDCl 3 ) δ: 1.20 (s, 9H, 3×CH 3 ), 4.17 (s, 3H, OCH 3 ), 7.09 (d, J=8.0Hz, 1H, C 6 h 4 3-H), 7.16 (t, J=8.0Hz, 1H, C 6 h 4 5-H), 7.59 (td, J=8.0Hz, J=2.2Hz, 1H, C 6 h 4 4-H), 8.12(s, 1H, C 2 N 3 h 2 3-H), 8.27 (s, 1H, C 2 N 3 h 2 ...
Embodiment 3
[0022] Preparation of N-[4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-yl]-3-nitrobenzamide
[0023] According to the method of Example 2, 4-tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-amine reacted with 3-nitrobenzoic acid for 5.0h to obtain N-[4 - tert-butyl-5-(1,2,4-triazol-1-yl)thiazol-2-yl]-3-nitrobenzamide, yield 84.4%, m.p.207~211℃. 1 H NMR (400MHz, CDCl 3 ) δ: 1.20 (s, 9H, 3×CH 3 ), 7.79 (t, J=8.0Hz, 1H, C 6 h 4 5-H), 8.15(s, 1H, C 2 N 3 h 23-H), 8.31 (s, 1H, C 2 N 3 h 2 5-H), 8.41 (d, J=8.0Hz, 1H, C 6 h 4 6-H), 8.50 (d, J=9.6Hz, 1H, C 6 h 4 4-H), 8.89 (s, 1H, C 6 h 4 2-H).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com